In addition to that multiple cases with bulk achieved 80% ORR, we have also noticed that in one patient of CD5‐positive DLBCL with testicular involvement also achieved CR, suggesting that anti‐CD19 and anti‐CD20 CAR‐T cells are capable of passing the blood‐testis barrier. The gene discussed is CD19; the disease is diffuse large B-cell lymphoma.